default provider image
  • Telehealth Visits
bch logo

Jessica Keyser, PhD, MA

Psychology (Child and Adolescent Psychology)
Pediatric Eating Disorders Mission Bay
877-822-4453
default provider image
default provider image
bch logo

Jessica Keyser, PhD, MA

Psychology (Child and Adolescent Psychology)
Pediatric Eating Disorders Mission Bay
877-822-4453
  • Telehealth Visits

On this page

About me

Jessica Keyser is a psychologist who specializes in caring for adolescents and young adults with eating disorders. She is also highly skilled in treating conditions that often occur alongside eating disorders, such as anxiety, depression and substance abuse. In her practice, she conducts assessments and provides therapies proven effective in the treatment of eating disorders, including cognitive behavioral therapy and family-based treatment.

In addition to treating patients, Keyser supervises psychology trainees and helps coordinate their training in the UCSF Eating Disorders Program.

Keyser received both her doctorate and master's degree in clinical psychology from Temple University, with an emphasis in developmental psychopathology. She also has a bachelor's degree in psychology from the University of California, Berkeley. She completed a fellowship at the San Francisco Veterans Affairs Health Care System.

Keyser has contributed to two books, Understanding Bipolar Disorder: A Developmental Psychopathology Approach and Risk Factors in Depression.

Education

School

  • PHD, Temple University

Academic Title

  • Health Sciences Clinical Professor

Care Keywords

  • Services
    • Psychology (Child and Adolescent Psychology)

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.